Generate a tailored SOP for Dr. Robert Screaton. Improve your application with a focused, well-structured draft.
Robert Screaton received his undergraduate training at McGill University in Montreal, Canada, before pursuing post-doctoral studies at Burnham Institute and Salk Institute in California. From 2005 to 2015, he was a Senior Scientist at the Children’s Hospital of Eastern Ontario Research Institute and held the position of Associate Professor at the University of Ottawa, where he was awarded a Canada Research Chair in Apoptotic Signaling. His research focuses on finding cures for Type 1 and Type 2 diabetes, specifically understanding how pancreatic beta cells respond to extracellular cues to maintain their function and survival. He utilizes high-throughput functional genomic imaging screens to identify novel players in cell signaling pathways. His work also investigates mitochondrial function in insulin-producing cells, particularly the role of ROMO1, which is essential for preventing diabetes. Screaton has developed a kinase screening platform to identify critical nodes in signal transduction pathways. Additionally, he holds various leadership roles and has received several awards for his contributions to diabetes research and mentorship.
Children’s Hospital of Eastern Ontario Research Institute • Ottawa, ON, Canada
Conducted research focused on Type 1 and Type 2 diabetes, exploring cellular responses and mechanisms for insulin production.
University of Ottawa • Ottawa, ON, Canada
Held a Canada Research Chair in Apoptotic Signaling and taught courses while conducting significant research in diabetes.
Department of Sociology